Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.36, $0.05 better than the analyst estimate of $0.31. Revenue for the quarter came in at $16.13 million versus the consensus estimate of $15.66 million.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.